This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Tvax Biomedical I, LLC. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Innovations by Gary Wood in Cancer Therapy
Introduction
Gary Wood is an accomplished inventor based in Olathe, KS (US). He has made significant contributions to the field of cancer treatment through his innovative approaches. With a total of 2 patents, his work focuses on enhancing the efficacy of adoptive T cell therapy.
Latest Patents
One of Gary Wood's latest patents is titled "Methods for combining adoptive T cell therapy with oncolytic virus adjunct therapy." This invention aims to augment the effects of adoptive T cell therapy, such as TVAX Immunotherapy, by using adjunct treatment with an oncolytic virus, like a vaccinia virus. This method is designed to treat various types of cancer and other proliferative disorders. Additionally, immunomodulatory compounds can be utilized to further enhance the effects of the therapy.
Career Highlights
Gary Wood is currently associated with Tvax Biomedical I, LLC, where he continues to develop innovative solutions for cancer treatment. His work is pivotal in advancing therapeutic options for patients facing challenging diagnoses.
Collaborations
Gary collaborates with Jochen Stritzker, contributing to the development of groundbreaking therapies in the field of immunotherapy.
Conclusion
Gary Wood's innovative work in cancer therapy exemplifies the potential of combining different treatment modalities to improve patient outcomes. His contributions are vital in the ongoing fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile